● Recruiting

Comparing The Safety And Efficacy Of DEFENCATH® In Reducing Central-Line Bloodstream Infections (CLABSIs) In Adults Receiving Total Parenteral Nutrition Through A Central Venous Catheter (CVC)

Condition: Central Line Associated Blood Stream Infections (CLABSI) · Sponsor: CorMedix

PhasePhase 3

Planned participants200

Who can joinAll sexes, 18 Years to no upper limit

Healthy volunteersNo

About this study

This is a Phase 3, randomized, double-blind, controlled, adaptive, 2-arm, multicenter study to demonstrate the efficacy and safety of DefenCath in adult participants receiving home Total Parenteral Nutrition (TPN) via Central Venous Catheter (CVC) compared with heparin.

This description comes directly from the study's public registry record.

Talk to the study team

Liz Hurlburt, Chief Clinical Strategy & Operations Officer · 908-517-9500 · lhurlburt@cormedix.com

Always discuss trial participation with your own doctor first.

Locations (22)

University of California Los Angeles	Los Angeles, California, United States	Recruiting
MedStar Health Research Institute	Washington D.C., District of Columbia, United States	Recruiting
Bioresearch Partner	Doral, Florida, United States	Recruiting
Emory University Hospital - GCRC	Atlanta, Georgia, United States	Recruiting
University of Chicago Medical Center	Chicago, Illinois, United States	Recruiting
University of Iowa Health Care	Iowa City, Iowa, United States	Recruiting
Johns Hopkins Clinical Research Unit	Baltimore, Maryland, United States	Recruiting
Mayo Clinic	Rochester, Minnesota, United States	Recruiting
University of Nebraska Medical Center	Omaha, Nebraska, United States	Recruiting
Mount Sinai Medical Center	New York, New York, United States	Recruiting
Columbia University Irving Medical Center	New York, New York, United States	Recruiting
Duke University Hospital	Durham, North Carolina, United States	Withdrawn

+ 10 more locations — full list on the registry record.

Follow this study

Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.

We email about this public record only. Unsubscribe anytime with one click. Never medical advice.

Is this your study? This page was generated automatically from the public registry record. Sponsors can claim it — free — to add branding and verified contact routing. Claim this page →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.

Source record: clinicaltrials.gov/study/NCT06822426